Novavax, Inc (NASDAQ:NVAX) shares, rose in value, with the stock price up by 0.08% to the previous day’s close as strong demand from buyers drove the stock to $6.30.
Actively observing the price movement in the recent trading, the stock is buoying the session at $6.30, falling within a range of $6.26 and $6.37. The value of beta (5-year monthly) is 2.771 whereas the PE ratio is 2.38 over 12-month period. Referring to stock’s 52-week performance, its high was $17.81, and the low was $5.01. On the whole, NVAX has fluctuated by -17.90% over the past month.
With the market capitalization of Novavax, Inc currently standing at about $1.02 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
The stock’s technical analysis shows that the price of NVAX currently trading nearly -10.70% and -5.98% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.23, while the 7-day volatility ratio is showing 3.80% which for the 30-day chart, stands at 3.80%. Furthermore, Novavax, Inc (NVAX)’s beta value is 2.77, and its average true range (ATR) is 0.44.
A comparison of Novavax, Inc (NVAX) with its peers suggests the former has fared considerably weaker in the market. NVAX showed an intraday change of 0.08% in today’s session so far, and over the past year, it shrunk by -55.12%%.
Data on historical trading for Novavax, Inc (NASDAQ:NVAX) indicates that the trading volumes over the past 10 days have averaged 5.87 and over the past 3 months, they’ve averaged 8.63 million. According to company’s latest data on outstanding shares, there are 161.96 million shares outstanding.
Nearly 8.90% of Novavax, Inc’s shares belong to company insiders and institutional investors own 56.77% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 44.7 million shares as on 2025-05-30, resulting in a short ratio of 3.34. According to the data, the short interest in Novavax, Inc (NVAX) stood at 2770.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 42.33 million. The stock has fallen by -21.58% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NVAX stock heading into the next quarter.
